Document is current
Any future updates will be listed below
-
Authors
He, Fei
Sun, Yancai
Zhang, Wenzhou
Wu, Qiongshi
Xu, Donghang
Bai, Zaixian
Hao, Zhiying
Feng, Weiyi
Zhang, Kanghuai
Liu, Jiang
Dong, Mei
Liu, Guangxuan
Li, Guohui
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04060290 at ClinicalTrials.govDocuments that mention this clinical trial
Safety and efficacy of generic nab-paclitaxel-based therapy in Chinese patients with malignant tumors in a real-world setting: a multicenter prospective observational study
https://doi.org/10.1007/s12672-024-01609-6
- License Information
-
More Information
Article History
Received: 12 June 2024
Accepted: 19 November 2024
First Online: 26 November 2024
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines, and this study was approved by the Research Ethics Committee of Cancer Hospital Chinese Academy of Medical Sciences (Ethical approval number: 19/14–1944). Written informed consent was obtained from all patients. This study was registered with Clinical Trials.gov (NCT04060290).
: The authors declare no competing interests.
